Chemobrain - A Troubling Side Effect of ChemotherapyMarta Banach1*, and Judyta K Juranek2,3
- *Corresponding Author:
- Dr. Marta Banach
Department of Neurology
Collegium Medicum, Jagiellonian University
Ul Botaniczna 3, 31-503 Krakow
E-mail: [email protected]
Received date: March 31, 2017; Accepted date: April 17, 2017; Published date: April 21, 2017
Citation: Banach M, Juranek JK (2017) Chemobrain – A Troubling Side Effect of Chemotherapy. J Depress Anxiety S11:002. doi:10.4172/2167-1044.S11-002
Copyright: © 2017 Banach M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Introduction: The term chemobrain is a short name for chemotherapy associated cognitive dysfunction. So far there is neither clear definition of the term chemobrain nor its epidemiology or pathogenesis are known and there have been no prospective studies addressing this condition. Method: Here, in this short review we provide an overview on the most recent findings of chemobrain pathogenesis, prevention and available treatment. We take a novel perspective on the role of blood-brain barrier in the development of chemotherapy associated cognitive dysfunction and discus briefly new and upcoming treatment.